2022 annual financial data

Dianthus Therapeutics 2022 Net margin

Dianthus Therapeutics 2022 net margin with verified reported values.

Direct answer

Net margin was -443.76%.

Operating income was -29,705,000 USD and net income was -28,476,000 USD.
Operating cash flow was -29,070,000 USD.

Get free Dianthus Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6,417,000 USD
Operating income
-29,705,000 USD
Net income
-28,476,000 USD
Operating cash flow
-29,070,000 USD